BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30052271)

  • 1. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009650. PubMed ID: 25927091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Rosenfeld M; Rayner O; Smyth AR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Rosenfeld M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD001912. PubMed ID: 28417451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Abbott L; Plummer A; Hoo ZH; Wildman M
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006682. PubMed ID: 31487382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD001912. PubMed ID: 25419599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Wood DM; Smyth AR
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotics for cystic fibrosis.
    Smyth A; Walters S
    Cochrane Database Syst Rev; 2003; (3):CD001912. PubMed ID: 12917916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005405. PubMed ID: 24170644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Jahnke N; Waters V
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.